Trademark Search  /  ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFLAMMATORY ARTHRITIS AND TO EVALUATE SAFETY AND TOLERABILITY

ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFLAMMATORY ARTHRITIS AND TO EVALUATE SAFETY AND TOLERABILITY

○ Dead · Cancelled

U.S. federal trademark · Serial No. 77233550 · Reg. No. 4142864

Mark
ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFLAMMATORY ARTHRITIS AND TO EVALUATE SAFETY AND TOLERABILITY
Status
Cancelled
Serial Number
77233550
Registration No.
4142864
Filing Date
July 19, 2007
Registration Date
May 15, 2012
Class(es)
Class 042

Owners

Bristol-Myers Squibb Company
03 · New York, NY, US
Bristol-Myers Squibb Company
03 · New York, NY, US
Bristol-Myers Squibb Company
03 · New York, NY, US

Goods & Services

medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFLAMMATORY ARTHRITIS AND TO EVALUATE SAFETY AND TOLERABILITY" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.